Ling Wong is the Founder and General Partner of Highbury Group. See portfolio, sector focus and contact routes.
Ling Wong is the Founder and General Partner of Highbury Group, a Seattle-based venture firm she established in 2014, bringing over 15 years of experience from roles including founding the a16z Bio + Health fund and advising at Lightspeed Venture Partners[5][7][8]. Her investment thesis targets seed through Series B stages in consumer health, climate-tech, biotech, digital health, AI, and hospital services, with a geographic focus on the United States[4][9]. Typical check sizes range from $500,000 to $50 million, with a sweet spot around $10 million, and she often acts as a lead investor given her solo General Partner status at Highbury[4][10]. Notable portfolio companies include Devoted Health, Stripe, Notion, and Orca Bio, with her track record spanning more than fifteen $1B+ companies[1][7][8]. Wong’s distinctive point of view stems from her PhD in Bioengineering and Global Health from Harvard, where she created the world’s first inhaled TB vaccine, blending scientific rigor with venture strategy[4][7]. She has publicly highlighted her work on global health portfolios at the Gates Foundation and exits like Anacor (acquired by Pfizer for $5.2B) and Slack[7].
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Seattle.
Investors like Ling Wong · Full investor directory · Investor access · Company funding database